Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3TMH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $12,467 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Skyrizi 360 mg/2.4 mL on-body injectors on January 13, 2026, with completion targeted for February 4, 2026. This non-set-aside award represents a task order issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $1 billion through December 2026. Skyrizi, a biologic medication used for treating inflammatory skin conditions, will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), serves as a critical pharmaceutical vendor for federal military and veteran healthcare systems. The company's comprehensive IDC with DLA enables efficient fulfillment of pharmaceutical supply needs across multiple therapeutic domains, allowing the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems to procure essential medications and medical supplies. This delivery order exemplifies the vendor's role in supporting military treatment facilities and federal healthcare programs through competitively awarded, firm fixed-price contract structures.
Quick answers
Who was awarded contract SPE2DR26F3TMH?
SPE2DR26F3TMH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F3TMH worth?
The government has obligated $12,467 on SPE2DR26F3TMH.
Is contract SPE2DR26F3TMH an order under another contract?
Yes. SPE2DR26F3TMH is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TMH competed?
The extent of competition for SPE2DR26F3TMH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award